ArticleFrontiers in oncology2021

Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy.

Xiaoqian Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.